Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Algorithms × 1 year × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

pembrolizumab 382 Carboplatin 266 Nivolumab 265 Specimen Handling 257 Magnetic Resonance Spectroscopy 243 Cyclophosphamide 243 Cisplatin 206 Radiotherapy 196 Paclitaxel 191 Biopsy 167 Gemcitabine 159 Dexamethasone 144 durvalumab 141 atezolizumab 126 Rituximab 119 Doxorubicin 119 Ipilimumab 117 Radiation 113 Bevacizumab 112 Lenalidomide 110 Docetaxel 105 Etoposide 103 Pemetrexed 99 Radiosurgery 96 Capecitabine 96 fludarabine 93 Oxaliplatin 92 Fluorouracil 92 venetoclax 91 Prednisone 91

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01806129 2025-06-13

EROS

Eastern Cooperative Oncology Group

Phase NA Active not recruiting

434 enrolled 9 charts

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡